|
[1]OTT JJ, STEVENS GA, GROEGER J, et al.Global epidemiology of hepatitis B virus infection:New estimates of age-specific HBsAg seroprevalence and endemicity[J].Vaccine, 2012, 30 (12) :2212-2219.
|
|
[2]SHI G, ZHANG SX.Meta-analysis on the positive rate of hepatitis B surface antigen among pregnant women in China[J].Chin Prevent Med, 2013, 14 (1) :26-30. (in Chinese) 石果, 张顺祥.我国孕妇乙肝表面抗原阳性率的Meta分析[J].中国预防医学杂志, 2013, 14 (1) :26-30.
|
|
[3]KWAN LC, HO YY, LEE SS.The declining HBsAg carriage rate in pregnant women in Hong Kong[J].Epidemiol Infect, 1997, 119 (2) :281-283.
|
|
[4]FRAMBO AA, ATASHILI J, FON PN, et al.Prevalence of HB-sAg and knowledge about hepatitis B in pregnancy in the Buea Health District, Cameroon:A cross-sectional study[J].BMCRes Notes, 2014, 7:394.
|
|
[5]TAN J, LIU X, MAO X, et al.HBsAg positivity during pregnancy and adverse maternal outcomes:A retrospective cohort analysis[J].J Viral Hepat, 2016, 23 (10) :812-819.
|
|
[6]LIU J, ZHANG S, LIU M, et al.Maternal pre-pregnancy infection with hepatitis B virus and the risk of preterm birth:Apopulation-based cohort study[J].Lancet Glob Health, 2017, 5 (6) :e624-e632.
|
|
[7]CUI AM, CHENG XY, SHAO JG, et al.Maternal hepatitis B virus carrier status and pregnancy outcomes:A prospective cohort study[J].BMC Pregnancy Childbirth, 2016, 16:87.
|
|
[8]WONG S, CHAN LY, YU V, et al.Hepatitis B carrier and perinatal outcome in singleton pregnancy[J].Am J Perinatol, 1999, 16 (9) :485-488.
|
|
[9]CONNELL LE, SALIHU HM, SALEMI JL, et al.Maternal hepatitis B and hepatitis C carrier status and perinatal outcomes[J].Liver Int, 2011, 31 (8) :1163-1170.
|
|
[10]CHEN J, ZHANG S, ZHOU YH, et al.Minimal adverse influence of maternal hepatitis B carrier status on perinatal outcomes and child’s growth[J].J Matern Fetal Neonatal Med, 2015, 28 (18) :2192-2196.
|
|
[11]CHANG CY, AZIZ N, POONGKUNRAN M, et al.Serum aminotransferase flares in pregnant and postpartum women with current or prior treatment for chronic hepatitis B[J].J Clin Gastroenterol, 2018, 52 (3) :255-261.
|
|
[12]ZHUANG X, CUI AM, WANG Q, et al.Liver dysfunction during pregnancy and its association of with preterm birth in China:A prospective cohort study[J].EBio Medicine, 2017, 26:152-156.
|
|
[13]CUNDY T, ACKERMANN E, RYAN EA.Gestational diabetes:New criteria may triple the prevalence but effect on outcomes is unclear[J].BMJ, 2014, 348:g1567.
|
|
[14]KONG D, LIU H, WEI S, et al.A meta-analysis of the association between gestational diabetes mellitus and chronic hepatitis B infection during pregnancy[J].BMC Res Notes, 2014, 7:139.
|
|
[15]LAO TT, TSE KY, CHAN LY, et al.HBsAg carrier status and the association between gestational diabetes with increased serum ferritin concentration in Chinese women[J].Diabetes Care, 2003, 26 (11) :3011-3016.
|
|
[16]TO WW, CHEUNG W, MOK KM.Hepatitis B surface antigen carrier status and its correlation to gestational hypertension[J].Aust N Z J Obstet Gynaecol, 2003, 43 (2) :119-122.
|
|
[17]TSE KY, HO LH, LAO T.The impact of maternal HBs Ag carrier status on pregnancy outcomes:A case-control study[J].J Hepatol, 2005, 43 (5) :771-775.
|
|
[18]LAO TT, CHAN BC, LEUNG WC, et al.Maternal hepatitis Binfection and gestational diabetes mellitus[J].J Hepatol, 2007, 47 (1) :46-50.
|
|
[19]LAO TT, CHUNG MK, CHEUNG TK, et al.Antenatal hepatitis B and increased risk of gestational diabetes mellitus-Implications for obstetric care[J].J Infect, 2016, 72 (5) :625-626.
|
|
[20]SAFIR A, LEVY A, SIKULER E, et al.Maternal hepatitis B virus or hepatitis C virus carrier status as an independent risk factor for adverse perinatal outcome[J].Liver Int, 2010, 30 (5) :765-770.
|
|
[21]REDDICK KL, JHAVERI R, GANDHI M, et al.Pregnancy outcomes associated with viral hepatitis[J].J Viral Hepat, 2011, 18 (7) :e394-e398.
|
|
[22]LAO TT, SAHOTA DS, CHENG YK, et al.Maternal hepatitis Bsurface antigen status and incidence of pre-eclampsia[J].JViral Hepat, 2013, 20 (5) :343-349.
|
|
[23]TAN J, MAO X, ZHANG G, et al.Hepatitis B surface antigen positivity during pregnancy and risk of gestational diabetes mellitus:A systematic review and meta-analysis[J].J Viral Hepat, 2018, 25 (11) :1372-1383.
|
|
[24]MAGHBOOLI Z, HOSSEIN-NEZHAD A, RAHMANI M, et al.Relationship between leptin concentration and insulin resistance[J].Honn Metab Res, 2007, 39 (12) :903-907.
|
|
[25]MURAKAMI S.Hepatitis B virus X protein:Structure, function and biology[J].Intervirology, 1999, 42 (2-3) :81-99.
|
|
[26]WINKLER G, CSEH K, BARANYI E, et al.Tumour necrosis factor system in insulin resistance in gestational diabetes[J].Diabetes Res Clin Pract, 2002, 56 (2) :93-99.
|
|
[27]BOZKAYA H, BOZDAYI M, TURKYILMAZ R, et al.Circulating IL-2, IL-10 and TNF-alpha in chronic hepatitis B:Their relations to HBe Ag status and the activity of liver disease[J].Hepatogastroenterology, 2000, 47 (36) :1675-1679.
|
|
[28]LEE JG, LEE S, KIM YJ, et al.Association of chronic viral hepatitis B with insulin resistance[J].World J Gastroenterol, 2012, 18 (42) :6120-6126.
|
|
[29]WANG J, LU W, LI J, et al.Hemodynamic effects of reninangiotensin-aldosterone inhibitor andβ-blocker combination therapy vs.β-blocker monotherapy for portal hypertension in cirrhosis:A meta-analysis[J].Exp Ther Med, 2017, 13 (5) :1977-1985.
|
|
[30]MA X, SUN D, LI C, et al.Chronic hepatitis B virus infection and preterm labor (birth) in pregnant women-an updated systematic review and meta-analysis[J].J Med Virol, 2018, 90 (1) :93-100.
|
|
[31] CHENG L, YANG XH, HU JN.Clinical features and management strategies of re-pregnant women with chronic hepatitis B virus infection after implementation of"two-child policy"[J].Chin JClin Infect Dis, 2017, 10 (3) :181-186. (in Chinese) 程丽, 杨小红, 胡健女.“全面二孩”后合并慢性乙型肝炎病毒感染再妊娠妇女临床特点分析[J].中华临床感染病杂志, 2017, 10 (3) :181-186.
|
|
[32]XIN X, WANG Y, CHENG J, et al.Seroepidemiological survey of hepatitis B virus infection among 764, 460 women of childbearing age in rural China:A cross-sectional study[J].JClin Virol, 2016, 81:47-52.
|
DownLoad: